BofA raised the firm’s price target on Delek US (DK) to $24 from $14 and keeps an Underperform rating on the shares as part of a note in which the firm revised estimates and targets for its refining sector coverage.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US upgraded to Outperform from Peer Perform at Wolfe Research
- Delek US price target lowered to $15 from $18 at TD Cowen
- Sell Rating for Delek US Holdings Due to Revised Valuation and Uncertainty in Small Refinery Exemptions
- Delek US Earnings Call: Progress Amid Challenges
- Delek US Reports Q2 2025 Financial Results